Skip to content
10-Q

Quarterly Report

PRESSURE BIOSCIENCES, INC.

0001493152-23-017552

← back to feed
Filed
May 15, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 10, 2023 16.77M sh
Cash And Equivalents Q1 2023 · Mar 31, 2023 $239.02K
Cash And Equivalents Q1 2023 · Dec 31, 2022 $3.87K
Current Liabilities Q1 2023 · Mar 31, 2023 $34.4M
Current Liabilities Q1 2023 · Dec 31, 2022 $34.4M
Total Liabilities Q1 2023 · Mar 31, 2023 $34.66M
Total Liabilities Q1 2023 · Dec 31, 2022 $34.7M
Current Assets Q1 2023 · Mar 31, 2023 $1.55M
Current Assets Q1 2023 · Dec 31, 2022 $1.24M
Total Assets Q1 2023 · Mar 31, 2023 $2.21M
Total Assets Q1 2023 · Dec 31, 2022 $2.01M
Capex Q1 2023 · Mar 31, 2022 $1.14K
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$756.28K
Stockholders Equity Q1 2023 · Mar 31, 2022 −$24.75M
Stockholders Equity Q1 2023 · Dec 31, 2021 −$22.21M
Eps Basic Q1 2023 · Mar 31, 2022 −$0.48
Sga Expense Q1 2023 · Mar 31, 2022 $903.89K
Rd Expense Q1 2023 · Mar 31, 2022 $281.59K
Net Income Q1 2023 · Mar 31, 2022 −$4.24M
Operating Income Q1 2023 · Mar 31, 2022 −$1.09M
Cost Of Revenue Q1 2023 · Mar 31, 2022 $314.36K
Revenue Q1 2023 · Mar 31, 2022 $480K